Clinical trials
Follow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Proteflazid
- Development stage
- Unknown
- Lead developer
- PhytoHealth
- Modality
- Small Molecules
- Administration
- Oral
01
Overview
Proteflazid is a direct-acting antiviral herbal extract developed by Ecopharm. It is derived from wild cereals *Deschampsia caespitosa L.* (tufted hair grass) and *Calamagrostis epigeios L.* (bush grass) and contains flavonoid glycosides as its active components. The drug exerts its antiviral effect by inhibiting viral DNA polymerase and thymidine kinase, which are essential for the replication of both DNA and RNA viruses. Additionally, Proteflazid induces the synthesis of endogenous alpha- and gamma-interferons to physiologically active levels, thereby enhancing the host's non-specific immune response. It is indicated for a broad spectrum of viral infections, including herpes simplex virus (types 1-5), human papillomavirus (including oncogenic strains), hepatitis B and C, HIV/AIDS, influenza, and coronavirus (COVID-19). Formulated as oral drops, it has been approved for clinical use in Ukraine and other regions for patients of all ages, including newborns.
- Brand names
- Proteflazid
- Other names
- Proteflazid Drops
02
Targets
Herpesvirus DNA polymeraseHSV-TK (Herpes simplex virus type 1 thymidine kinase (HSV1-TK))IFN-α (Interferon alpha-7)IFNG (Interferon gamma)TK2 (Thymidine kinase 2)DNA polymerase family
Beyond the preview
Go deeper on Proteflazid.
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Indications & development
Explore development by indication, patient population, and geography.
- Indications
- Development status
- Countries
Licensing & deals
Trace asset ownership, licensing agreements, and commercial partnerships.
- Partners
- Deal terms
- Milestones
Patents & exclusivity
Explore the patent landscape and regulatory exclusivity around an asset.
- Patents
- Expiration dates
- Exclusivity
Competitive landscape
Compare development programs by target, modality, and indication.
- Competing assets
- Targets
- Development stage
Research & analysis
Connect source evidence and development news to your research questions.
- Publications
- News
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Proteflazid.